what is gip and glp 1 Biology of Incretins: GLP-1 The activity of GLP-1 and

Tesamorelin clinical trials showed continued improvement out to 26 weeks, suggesting that longer protocols produce greater cumulative benefit

So even if there is existing debate, it seems that the trend is moving toward a real connection rather than a non-existent one

So essentially what I did is instead of you piecing it together from my podcast, social media clips, um, or the conflicting advice online, I gave you a clear roadmap

Best Pract Res Clin Endocrinol Metab (2009) 23(6):78192

However, its still a good idea to check your plans drug list (formulary) to be sure

For my medullary patients the ones with the FDA warning I'm still saying, until we have better data, I can't recommend it